Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations

v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue:        
Product revenue, net $ 17,839,000 $ 15,009,000 $ 33,760,000 $ 28,148,000
Other revenue 671,000   711,000  
Total revenue 18,510,000 15,009,000 34,471,000 28,148,000
Operating expenses        
Cost of goods sold - (excluding amortization of acquired intangible assets) 6,143,000 4,939,000 12,361,000 9,729,000
Amortization of acquired intangible assets 969,000 1,064,000 2,095,000 2,129,000
Research and development 54,000   54,000 39,000
Selling, general and administrative 10,888,000 11,882,000 20,997,000 22,451,000
Total operating expenses 18,054,000 17,885,000 35,507,000 34,348,000
Income (loss) from operations 456,000 (2,876,000) (1,036,000) (6,200,000)
Other expense (income)        
Interest income (154,000) (138,000) (311,000) (287,000)
Interest expense 906,000 937,000 1,798,000 1,828,000
Foreign exchange transaction losses 1,000 61,000 4,000 68,000
Total other expense 753,000 860,000 1,491,000 1,609,000
Loss before income taxes (297,000) (3,736,000) (2,527,000) (7,809,000)
Income tax expense 15,000 60,000 15,000 60,000
Net loss $ (312,000) $ (3,796,000) $ (2,542,000) $ (7,869,000)
Net loss per common share:        
Basic (In dollars per share) $ (0.01) $ (0.16) $ (0.09) $ (0.34)
Diluted (In dollars per share) $ (0.01) $ (0.16) $ (0.09) $ (0.34)
Weighted average number of common shares:        
Basic (In shares) 27,493,693 23,290,806 27,399,881 22,952,801
Diluted (In shares) 27,493,693 23,290,806 27,399,881 22,952,801